About Leicester Royal Infirmary; Dept. of Medical Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
Genentech, Inc.
2
Clinical Trials at Leicester Royal Infirmary; Dept. of Medical Oncology
During the past decade, Leicester Royal Infirmary; Dept. of Medical Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
2012-01-20
2016-03-30
Completed
501
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL)
2014-12-01
2018-03-16
Completed
163
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
2015-01-13
2018-11-08
Completed
931
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Leicester Royal Infirmary; Dept. of Medical Oncology"
#1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Leicester Royal Infirmary; Dept. of Medical Oncology
According to Clinical.Site data, the most researched conditions in "Leicester Royal Infirmary; Dept. of Medical Oncology" are
"Breast Cancer" (2 trials), "Adenocarcinoma" (1 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "B-cell Lymphoma" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Leicester Royal Infirmary; Dept. of Medical Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Leicester Royal Infirmary; Dept. of Medical Oncology
Most popular intervention types in "Leicester Royal Infirmary; Dept. of Medical Oncology" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (3 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials), "Atezolizumab" (2 trials) and "Pembrolizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Leicester Royal Infirmary; Dept. of Medical Oncology
The vast majority of trials in "Leicester Royal Infirmary; Dept. of Medical Oncology" are
11 trials for "All" genders.
Clinical Trials Status at Leicester Royal Infirmary; Dept. of Medical Oncology
Currently, there are NaN active trials in "Leicester Royal Infirmary; Dept. of Medical Oncology".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Leicester Royal Infirmary; Dept. of Medical Oncology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Leicester Royal Infirmary; Dept. of Medical Oncology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".